Baseline Serum Vascular Endothelial Growth Factor (VEGF) Concentration as Predictive Factor of Response to Infliximab (Remicade) Therapy in Patients With Active Ankylosing Spondylitis Despite Conventional Treatment: a Multicenter Pilot Study.
Phase of Trial: Phase IV
Latest Information Update: 15 May 2017
At a glance
- Drugs Infliximab (Primary)
- Indications Ankylosing spondylitis
- Focus Therapeutic Use
- Sponsors Schering-Plough
- 05 May 2014 Added association merck sharp and dohme as per NCT
- 15 Nov 2008 New trial record.